(Q38151449)

29 August 2017

Treatment of the obese patient in primary care: targeting and meeting goals and expectations (English)

1 reference

29 August 2017

0 references

1

George Bray

1 reference

29 August 2017

Michelle Look

2

1 reference

PubMed ID

24113665

29 August 2017

Donna Ryan

series ordinal

3

1 reference

PubMed ID

24113665

29 August 2017

language of work or name

English

0 references

publication date

1 September 2013

1 reference

29 August 2017

Postgraduate Medicine

1 reference

29 August 2017

125

1 reference

29 August 2017

5

1 reference

29 August 2017

67-77

1 reference

The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences

29 August 2017

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Association of body mass index with self-report and performance-based measures of balance and mobility

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Standards of medical care in diabetes--2013

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Quantification of the effect of energy imbalance on bodyweight

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Weight loss goals of patients in a health maintenance organization.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Medical Consequences of Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Lipotoxicity: when tissues overeat

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Physical activity, body mass index, and diabetes risk in men: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Guidelines for healthy weight

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Lipoprotein subfractions and cardiovascular disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Treatment of lipid disorders in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

The relationship between body mass index and hip osteoarthritis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Fitness and fatness as predictors of mortality from all causes and from cardiovascular disease in men and women in the lipid research clinics study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Estimates of body composition with dual-energy X-ray absorptiometry in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Effect of weight loss with lifestyle intervention on risk of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Intensive lifestyle intervention improves physical function among obese adults with knee pain: findings from the Look AHEAD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Bariatric surgery patients' views of their physicians' weight-related attitudes and practices

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Predictors of weight control advice in primary care practices: patient health and psychosocial characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Perceived barriers to weight management in primary care--perspectives of patients and providers

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

A silent response to the obesity epidemic: decline in US physician weight counseling

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Barriers to providing nutrition counseling by physicians: a survey of primary care practitioners.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

New and emerging weight management strategies for busy ambulatory settings: a scientific statement from the American Heart Association endorsed by the Society of Behavioral Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Myths, presumptions, and facts about obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

One-year weight losses in the Look AHEAD study: factors associated with success

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Comparative effectiveness of weight-loss interventions in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Medical therapy for the patient with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Managing obesity in primary care practice: a narrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

A computer support program that helps clinicians provide patients with metabolic syndrome tailored counseling to promote weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

One-year results of the Think Health! study of weight management in primary care practices

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

A two-year randomized trial of obesity treatment in primary care practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP)

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Soc

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Review of meta-analytic comparisons of bariatric surgery with a focus on laparoscopic adjustable gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Bariatric surgery and long-term cardiovascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Health benefits of gastric bypass surgery after 6 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Effect of co-morbidity on the association of high body mass index with walking limitation among men and women aged 55 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

Adiposity as Compared with Physical Activity in Predicting Mortality among Women

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

The effect of obesity management on body image in patients seeking treatment at medical centers

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2013.09.2692

21 January 2018

Identifiers

DOI

10.3810/PGM.2013.09.2692

1 reference

29 August 2017

1 reference

PubMed ID

24113665